Sanofi : Strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER(1)GlobeNewsWire • 10/28/21
Giving Moderna's COVID-19 booster at the same time as Sanofi's flu is safe and effectiveMarket Watch • 10/08/21
Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidateGlobeNewsWire • 09/28/21